Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Vineet Kumar Gupta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0307-9485; OpenAlex author ID A5101874603. Sources: OpenAlex.

Their work

Papers
17 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: 4 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 17

  1. Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer Co-author DOI 10.64898/2025.12.04.691935↗
  2. Role of epigenetics in pancreatic ductal adenocarcinoma. First author DOI 10.2217/epi-2022-0177↗
  3. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215591↗
  4. Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Difference? Co-author DOI 10.1053/j.gastro.2021.12.256↗
  5. Targeting IRAK4 Signaling in PDAC: Turning the "Cold" Tumors to "Hot" Ones. Co-author DOI 10.1053/j.gastro.2022.03.036↗
  6. Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC. Co-author DOI 10.1080/19490976.2022.2096328↗
  7. Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2562↗
  8. Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2020.07.009↗
  9. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. First author DOI 10.1172/jci127515↗
  10. Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression,remodels extracellular matrix and sensitizes to anti-PD1 therapy First author DOI 10.1016/j.pan.2019.05.430↗
  11. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness". Co-author DOI 10.1038/s41419-019-1408-5↗
  12. O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. First author DOI 10.7150/thno.32615↗
  13. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Co-author DOI 10.1002/1878-0261.12322↗
  14. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Co-author DOI 10.1016/j.canlet.2018.09.028↗
  15. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Co-author DOI 10.1158/0008-5472.can-17-2320↗
  16. Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. First author DOI 10.1038/s41598-017-01696-2↗
  17. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer. First author DOI 10.1038/s41598-017-08447-3↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashok Kumar Saluja · 13 shared papers, 2017–2022 · strength 1.34
  2. Sulagna Banerjee · 12 shared papers, 2017–2022 · strength 1.20
  3. Nikita Sharma · 11 shared papers, 2017–2022 · strength 1.02
  4. Vikas Dudeja · 10 shared papers, 2017–2022 · strength 0.91
  5. Somnath Pandey · 4 shared papers, 2022–2023 · strength 0.85
  6. Shweta Lavania · 4 shared papers, 2022–2023 · strength 0.85
  7. Kousik Kesh · 7 shared papers, 2018–2022 · strength 0.69
  8. Bhuwan Giri · 6 shared papers, 2017–2022 · strength 0.57
  9. Patricia Dauer · 7 shared papers, 2017–2019 · strength 0.56
  10. Selwyn Maurice Vickers · 4 shared papers, 2018–2022 · strength 0.44
  11. Santanu Banerjee · 4 shared papers, 2018–2022 · strength 0.40
  12. Nipun B. Merchant · 2 shared papers, 2022–2025 · strength 0.33
  13. Haleh Amirian · 2 shared papers, 2022–2025 · strength 0.32
  14. Alice Nomura · 4 shared papers, 2017–2018 · strength 0.30
  15. Shrey Modi · 2 shared papers, 2022 · strength 0.28
  16. Beatriz Mateo-Victoriano · 2 shared papers, 2021–2022 · strength 0.25
  17. Anthony R. Ferrantella · 2 shared papers, 2019–2020 · strength 0.19
  18. Kathleen E. DelGiorno · 1 shared paper, 2025 · strength 0.19
  19. Oliver Gene McDonald · 1 shared paper, 2025 · strength 0.19
  20. Austin R. Dosch · 1 shared paper, 2025 · strength 0.19
  21. Jashodeep Datta · 1 shared paper, 2025 · strength 0.19
  22. Siddharth Mehra · 1 shared paper, 2025 · strength 0.19
  23. Supriya Srinivasan · 1 shared paper, 2025 · strength 0.19
  24. Nagaraj S. Nagathihalli · 1 shared paper, 2025 · strength 0.19
  25. Vrishketan Sethi · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.